Nitric oxide delivery via a permeable balloon catheter inhibits neointimal growth after arterial injury

Abstract Background Neointimal hyperplasia limits the longevity of vascular interventions. Nitric oxide (NO) is well known to inhibit neointimal hyperplasia. However, delivery of NO to the vasculature is challenging. Our study aims to evaluate the efficacy of delivering NO to the site of injury usin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of surgical research 2013-03, Vol.180 (1), p.35-42
Hauptverfasser: Havelka, George E., MD, Moreira, Edward S., PhD, Rodriguez, Monica P., MD, Tsihlis, Nick D., PhD, Wang, Zheng, Martínez, Janet, AAS, Hrabie, Joseph A., PhD, Kiefer, Larry K., PhD, Kibbe, Melina R., MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 42
container_issue 1
container_start_page 35
container_title The Journal of surgical research
container_volume 180
creator Havelka, George E., MD
Moreira, Edward S., PhD
Rodriguez, Monica P., MD
Tsihlis, Nick D., PhD
Wang, Zheng
Martínez, Janet, AAS
Hrabie, Joseph A., PhD
Kiefer, Larry K., PhD
Kibbe, Melina R., MD
description Abstract Background Neointimal hyperplasia limits the longevity of vascular interventions. Nitric oxide (NO) is well known to inhibit neointimal hyperplasia. However, delivery of NO to the vasculature is challenging. Our study aims to evaluate the efficacy of delivering NO to the site of injury using a permeable balloon catheter. Our hypothesis is that ultra-short duration NO delivery using a permeable balloon catheter will inhibit neointimal hyperplasia. Materials and methods Ten-week-old male Sprague-Dawley rats underwent carotid artery balloon injury. Groups included: (1) control, (2) injury, (3) injury + periadventitial NO, and (4) injury + endoluminal NO via permeable balloon catheter. The catheter was inflated to 5 atm pressure for 5 min. Arteries were harvested 2 wk following injury. Morphometric assessment for neointimal hyperplasia and immunohistochemical staining for inflammatory markers were performed. Results Injury increased neointimal hyperplasia compared with control (intima/media area [I/M] ratio 1.07 versus 0.11, respectively, P < 0.001). Periadventitial delivery of NO reduced the I/M area ratio compared with injury alone (55% decrease, P < 0.001). Endoluminal delivery of NO also reduced the I/M area ratio compared with injury alone (65% decrease; P  < 0.001). Both endoluminal and periadventitial NO affected the I/M ratio by reducing the intimal area (64% and 46%, respectively, P < 0.001) whereas neither affected the medial area. Periadventitial NO delivery increased lumen area ( P < 0.05), whereas endoluminal NO delivery increased circumference ( P < 0.05). Periadventitial NO delivery inhibited macrophage intimal infiltration compared with injury alone ( P < 0.05). Conclusions These data demonstrate that short-duration endoluminal NO delivery via permeable balloon catheters inhibits neointimal hyperplasia following arterial interventions. Endoluminal delivery of NO could become a focus for future clinical interventions.
doi_str_mv 10.1016/j.jss.2012.10.048
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3578007</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0022480412009687</els_id><sourcerecordid>1288993938</sourcerecordid><originalsourceid>FETCH-LOGICAL-c506t-160e842c7a8085798e3ad98d01a7e844c73efc14997ac704b115601c0f7487a83</originalsourceid><addsrcrecordid>eNp9Uk2P0zAQjRCILQs_gAvykUvKOE5iR0groRVf0goOwNlynGk7wY2L7XTpv8dRlxVw4GLLM--9Gc-bonjOYc2Bt6_G9RjjugJe5fcaavWgWHHomlK1UjwsVgBVVdYK6oviSYwj5HcnxePiohK8rUXLV8X2E6VAlvmfNCAb0NERw4kdyTDDDhj2aHqHrDfOeT8xa9IOEwZG0456SpFN6GlKtDeObYO_TTtmNgvAhHxSjtI0zuH0tHi0MS7is7v7svj27u3X6w_lzef3H6_f3JS2gTaVvAVUdWWlUaAa2SkUZujUANzInKitFLixvO46aayEuue8aYFb2MhaZZK4LK7Ouoe53-NgcUrBOH0IucNw0t6Q_jsz0U5v_VGLRioAmQVe3gkE_2PGmPSeokXnTP7pHDWvlOo60YmlFj9DbfAxBtzcl-GgF4P0qLNBejFoCWWDMufFn_3dM347kgGvzwDMUzoSBh0t4WRxoIA26cHTf-Wv_mFbRxNZ477jCePo5zDl8WuuY6VBf1k2ZFkQXgF0rZLiFz4GuAQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1288993938</pqid></control><display><type>article</type><title>Nitric oxide delivery via a permeable balloon catheter inhibits neointimal growth after arterial injury</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Havelka, George E., MD ; Moreira, Edward S., PhD ; Rodriguez, Monica P., MD ; Tsihlis, Nick D., PhD ; Wang, Zheng ; Martínez, Janet, AAS ; Hrabie, Joseph A., PhD ; Kiefer, Larry K., PhD ; Kibbe, Melina R., MD</creator><creatorcontrib>Havelka, George E., MD ; Moreira, Edward S., PhD ; Rodriguez, Monica P., MD ; Tsihlis, Nick D., PhD ; Wang, Zheng ; Martínez, Janet, AAS ; Hrabie, Joseph A., PhD ; Kiefer, Larry K., PhD ; Kibbe, Melina R., MD</creatorcontrib><description><![CDATA[Abstract Background Neointimal hyperplasia limits the longevity of vascular interventions. Nitric oxide (NO) is well known to inhibit neointimal hyperplasia. However, delivery of NO to the vasculature is challenging. Our study aims to evaluate the efficacy of delivering NO to the site of injury using a permeable balloon catheter. Our hypothesis is that ultra-short duration NO delivery using a permeable balloon catheter will inhibit neointimal hyperplasia. Materials and methods Ten-week-old male Sprague-Dawley rats underwent carotid artery balloon injury. Groups included: (1) control, (2) injury, (3) injury + periadventitial NO, and (4) injury + endoluminal NO via permeable balloon catheter. The catheter was inflated to 5 atm pressure for 5 min. Arteries were harvested 2 wk following injury. Morphometric assessment for neointimal hyperplasia and immunohistochemical staining for inflammatory markers were performed. Results Injury increased neointimal hyperplasia compared with control (intima/media area [I/M] ratio 1.07 versus 0.11, respectively, P < 0.001). Periadventitial delivery of NO reduced the I/M area ratio compared with injury alone (55% decrease, P < 0.001). Endoluminal delivery of NO also reduced the I/M area ratio compared with injury alone (65% decrease; P  < 0.001). Both endoluminal and periadventitial NO affected the I/M ratio by reducing the intimal area (64% and 46%, respectively, P < 0.001) whereas neither affected the medial area. Periadventitial NO delivery increased lumen area ( P < 0.05), whereas endoluminal NO delivery increased circumference ( P < 0.05). Periadventitial NO delivery inhibited macrophage intimal infiltration compared with injury alone ( P < 0.05). Conclusions These data demonstrate that short-duration endoluminal NO delivery via permeable balloon catheters inhibits neointimal hyperplasia following arterial interventions. Endoluminal delivery of NO could become a focus for future clinical interventions.]]></description><identifier>ISSN: 0022-4804</identifier><identifier>EISSN: 1095-8673</identifier><identifier>DOI: 10.1016/j.jss.2012.10.048</identifier><identifier>PMID: 23164361</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adventitia ; Angioplasty, Balloon ; Animals ; Carotid Artery Injuries - drug therapy ; Carotid Artery Injuries - pathology ; Endoluminal ; Hyperplasia ; Inflammation ; Intima ; Macrophage ; Male ; Media ; Neointima - pathology ; Neointimal hyperplasia ; Nitric oxide ; Nitric Oxide - administration &amp; dosage ; Permeability ; Rats ; Rats, Sprague-Dawley ; Restenosis ; Surgery</subject><ispartof>The Journal of surgical research, 2013-03, Vol.180 (1), p.35-42</ispartof><rights>2013</rights><rights>Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c506t-160e842c7a8085798e3ad98d01a7e844c73efc14997ac704b115601c0f7487a83</citedby><cites>FETCH-LOGICAL-c506t-160e842c7a8085798e3ad98d01a7e844c73efc14997ac704b115601c0f7487a83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0022480412009687$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23164361$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Havelka, George E., MD</creatorcontrib><creatorcontrib>Moreira, Edward S., PhD</creatorcontrib><creatorcontrib>Rodriguez, Monica P., MD</creatorcontrib><creatorcontrib>Tsihlis, Nick D., PhD</creatorcontrib><creatorcontrib>Wang, Zheng</creatorcontrib><creatorcontrib>Martínez, Janet, AAS</creatorcontrib><creatorcontrib>Hrabie, Joseph A., PhD</creatorcontrib><creatorcontrib>Kiefer, Larry K., PhD</creatorcontrib><creatorcontrib>Kibbe, Melina R., MD</creatorcontrib><title>Nitric oxide delivery via a permeable balloon catheter inhibits neointimal growth after arterial injury</title><title>The Journal of surgical research</title><addtitle>J Surg Res</addtitle><description><![CDATA[Abstract Background Neointimal hyperplasia limits the longevity of vascular interventions. Nitric oxide (NO) is well known to inhibit neointimal hyperplasia. However, delivery of NO to the vasculature is challenging. Our study aims to evaluate the efficacy of delivering NO to the site of injury using a permeable balloon catheter. Our hypothesis is that ultra-short duration NO delivery using a permeable balloon catheter will inhibit neointimal hyperplasia. Materials and methods Ten-week-old male Sprague-Dawley rats underwent carotid artery balloon injury. Groups included: (1) control, (2) injury, (3) injury + periadventitial NO, and (4) injury + endoluminal NO via permeable balloon catheter. The catheter was inflated to 5 atm pressure for 5 min. Arteries were harvested 2 wk following injury. Morphometric assessment for neointimal hyperplasia and immunohistochemical staining for inflammatory markers were performed. Results Injury increased neointimal hyperplasia compared with control (intima/media area [I/M] ratio 1.07 versus 0.11, respectively, P < 0.001). Periadventitial delivery of NO reduced the I/M area ratio compared with injury alone (55% decrease, P < 0.001). Endoluminal delivery of NO also reduced the I/M area ratio compared with injury alone (65% decrease; P  < 0.001). Both endoluminal and periadventitial NO affected the I/M ratio by reducing the intimal area (64% and 46%, respectively, P < 0.001) whereas neither affected the medial area. Periadventitial NO delivery increased lumen area ( P < 0.05), whereas endoluminal NO delivery increased circumference ( P < 0.05). Periadventitial NO delivery inhibited macrophage intimal infiltration compared with injury alone ( P < 0.05). Conclusions These data demonstrate that short-duration endoluminal NO delivery via permeable balloon catheters inhibits neointimal hyperplasia following arterial interventions. Endoluminal delivery of NO could become a focus for future clinical interventions.]]></description><subject>Adventitia</subject><subject>Angioplasty, Balloon</subject><subject>Animals</subject><subject>Carotid Artery Injuries - drug therapy</subject><subject>Carotid Artery Injuries - pathology</subject><subject>Endoluminal</subject><subject>Hyperplasia</subject><subject>Inflammation</subject><subject>Intima</subject><subject>Macrophage</subject><subject>Male</subject><subject>Media</subject><subject>Neointima - pathology</subject><subject>Neointimal hyperplasia</subject><subject>Nitric oxide</subject><subject>Nitric Oxide - administration &amp; dosage</subject><subject>Permeability</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Restenosis</subject><subject>Surgery</subject><issn>0022-4804</issn><issn>1095-8673</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9Uk2P0zAQjRCILQs_gAvykUvKOE5iR0groRVf0goOwNlynGk7wY2L7XTpv8dRlxVw4GLLM--9Gc-bonjOYc2Bt6_G9RjjugJe5fcaavWgWHHomlK1UjwsVgBVVdYK6oviSYwj5HcnxePiohK8rUXLV8X2E6VAlvmfNCAb0NERw4kdyTDDDhj2aHqHrDfOeT8xa9IOEwZG0456SpFN6GlKtDeObYO_TTtmNgvAhHxSjtI0zuH0tHi0MS7is7v7svj27u3X6w_lzef3H6_f3JS2gTaVvAVUdWWlUaAa2SkUZujUANzInKitFLixvO46aayEuue8aYFb2MhaZZK4LK7Ouoe53-NgcUrBOH0IucNw0t6Q_jsz0U5v_VGLRioAmQVe3gkE_2PGmPSeokXnTP7pHDWvlOo60YmlFj9DbfAxBtzcl-GgF4P0qLNBejFoCWWDMufFn_3dM347kgGvzwDMUzoSBh0t4WRxoIA26cHTf-Wv_mFbRxNZ477jCePo5zDl8WuuY6VBf1k2ZFkQXgF0rZLiFz4GuAQ</recordid><startdate>20130301</startdate><enddate>20130301</enddate><creator>Havelka, George E., MD</creator><creator>Moreira, Edward S., PhD</creator><creator>Rodriguez, Monica P., MD</creator><creator>Tsihlis, Nick D., PhD</creator><creator>Wang, Zheng</creator><creator>Martínez, Janet, AAS</creator><creator>Hrabie, Joseph A., PhD</creator><creator>Kiefer, Larry K., PhD</creator><creator>Kibbe, Melina R., MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20130301</creationdate><title>Nitric oxide delivery via a permeable balloon catheter inhibits neointimal growth after arterial injury</title><author>Havelka, George E., MD ; Moreira, Edward S., PhD ; Rodriguez, Monica P., MD ; Tsihlis, Nick D., PhD ; Wang, Zheng ; Martínez, Janet, AAS ; Hrabie, Joseph A., PhD ; Kiefer, Larry K., PhD ; Kibbe, Melina R., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c506t-160e842c7a8085798e3ad98d01a7e844c73efc14997ac704b115601c0f7487a83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adventitia</topic><topic>Angioplasty, Balloon</topic><topic>Animals</topic><topic>Carotid Artery Injuries - drug therapy</topic><topic>Carotid Artery Injuries - pathology</topic><topic>Endoluminal</topic><topic>Hyperplasia</topic><topic>Inflammation</topic><topic>Intima</topic><topic>Macrophage</topic><topic>Male</topic><topic>Media</topic><topic>Neointima - pathology</topic><topic>Neointimal hyperplasia</topic><topic>Nitric oxide</topic><topic>Nitric Oxide - administration &amp; dosage</topic><topic>Permeability</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Restenosis</topic><topic>Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Havelka, George E., MD</creatorcontrib><creatorcontrib>Moreira, Edward S., PhD</creatorcontrib><creatorcontrib>Rodriguez, Monica P., MD</creatorcontrib><creatorcontrib>Tsihlis, Nick D., PhD</creatorcontrib><creatorcontrib>Wang, Zheng</creatorcontrib><creatorcontrib>Martínez, Janet, AAS</creatorcontrib><creatorcontrib>Hrabie, Joseph A., PhD</creatorcontrib><creatorcontrib>Kiefer, Larry K., PhD</creatorcontrib><creatorcontrib>Kibbe, Melina R., MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of surgical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Havelka, George E., MD</au><au>Moreira, Edward S., PhD</au><au>Rodriguez, Monica P., MD</au><au>Tsihlis, Nick D., PhD</au><au>Wang, Zheng</au><au>Martínez, Janet, AAS</au><au>Hrabie, Joseph A., PhD</au><au>Kiefer, Larry K., PhD</au><au>Kibbe, Melina R., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nitric oxide delivery via a permeable balloon catheter inhibits neointimal growth after arterial injury</atitle><jtitle>The Journal of surgical research</jtitle><addtitle>J Surg Res</addtitle><date>2013-03-01</date><risdate>2013</risdate><volume>180</volume><issue>1</issue><spage>35</spage><epage>42</epage><pages>35-42</pages><issn>0022-4804</issn><eissn>1095-8673</eissn><abstract><![CDATA[Abstract Background Neointimal hyperplasia limits the longevity of vascular interventions. Nitric oxide (NO) is well known to inhibit neointimal hyperplasia. However, delivery of NO to the vasculature is challenging. Our study aims to evaluate the efficacy of delivering NO to the site of injury using a permeable balloon catheter. Our hypothesis is that ultra-short duration NO delivery using a permeable balloon catheter will inhibit neointimal hyperplasia. Materials and methods Ten-week-old male Sprague-Dawley rats underwent carotid artery balloon injury. Groups included: (1) control, (2) injury, (3) injury + periadventitial NO, and (4) injury + endoluminal NO via permeable balloon catheter. The catheter was inflated to 5 atm pressure for 5 min. Arteries were harvested 2 wk following injury. Morphometric assessment for neointimal hyperplasia and immunohistochemical staining for inflammatory markers were performed. Results Injury increased neointimal hyperplasia compared with control (intima/media area [I/M] ratio 1.07 versus 0.11, respectively, P < 0.001). Periadventitial delivery of NO reduced the I/M area ratio compared with injury alone (55% decrease, P < 0.001). Endoluminal delivery of NO also reduced the I/M area ratio compared with injury alone (65% decrease; P  < 0.001). Both endoluminal and periadventitial NO affected the I/M ratio by reducing the intimal area (64% and 46%, respectively, P < 0.001) whereas neither affected the medial area. Periadventitial NO delivery increased lumen area ( P < 0.05), whereas endoluminal NO delivery increased circumference ( P < 0.05). Periadventitial NO delivery inhibited macrophage intimal infiltration compared with injury alone ( P < 0.05). Conclusions These data demonstrate that short-duration endoluminal NO delivery via permeable balloon catheters inhibits neointimal hyperplasia following arterial interventions. Endoluminal delivery of NO could become a focus for future clinical interventions.]]></abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>23164361</pmid><doi>10.1016/j.jss.2012.10.048</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-4804
ispartof The Journal of surgical research, 2013-03, Vol.180 (1), p.35-42
issn 0022-4804
1095-8673
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3578007
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Adventitia
Angioplasty, Balloon
Animals
Carotid Artery Injuries - drug therapy
Carotid Artery Injuries - pathology
Endoluminal
Hyperplasia
Inflammation
Intima
Macrophage
Male
Media
Neointima - pathology
Neointimal hyperplasia
Nitric oxide
Nitric Oxide - administration & dosage
Permeability
Rats
Rats, Sprague-Dawley
Restenosis
Surgery
title Nitric oxide delivery via a permeable balloon catheter inhibits neointimal growth after arterial injury
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T10%3A50%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nitric%20oxide%20delivery%20via%20a%20permeable%20balloon%20catheter%20inhibits%20neointimal%20growth%20after%20arterial%20injury&rft.jtitle=The%20Journal%20of%20surgical%20research&rft.au=Havelka,%20George%20E.,%20MD&rft.date=2013-03-01&rft.volume=180&rft.issue=1&rft.spage=35&rft.epage=42&rft.pages=35-42&rft.issn=0022-4804&rft.eissn=1095-8673&rft_id=info:doi/10.1016/j.jss.2012.10.048&rft_dat=%3Cproquest_pubme%3E1288993938%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1288993938&rft_id=info:pmid/23164361&rft_els_id=1_s2_0_S0022480412009687&rfr_iscdi=true